Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer

KRAS mutation in tumor tissue is a well-known predictor of resistance to the treatment of anti-EGFR antibodies in metastatic colorectal cancers (mCRC). However, the prognostic value of low-frequency plasma circulating tumor DNA (ctDNA) KRAS mutation in predicting treatment resistance in pretreated m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chien-Yu, Shen, Ming-Yin, Chen, William Tzu-Liang, Yang, Chin-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381461/
https://www.ncbi.nlm.nih.gov/pubmed/37511664
http://dx.doi.org/10.3390/jpm13071051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381461/
https://www.ncbi.nlm.nih.gov/pubmed/37511664
http://dx.doi.org/10.3390/jpm13071051

Ejemplares similares